期刊文献+

中性粒细胞/淋巴细胞、血小板/淋巴细胞与胃肠道间质瘤Fletcher分级的关系 被引量:4

Correlations of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with the Fletcher grading of gastrointestinal stromal tumors
原文传递
导出
摘要 目的:探讨中性粒细胞/淋巴细胞、血小板/淋巴细胞比值与胃肠道间质瘤Fletcher分级的关系。方法选取广东省第二人民医院2005年2月到2012年12月间明确为GIST的49例患者临床资料进行回顾性研究,分析中性粒细胞/淋巴细胞(NLR)、血小板/淋巴细胞(PLR)比值与肿瘤最大直径、核分裂相以及Fletcher分级的关系,对两个指标术前判断胃肠道间质瘤(GIST)危险度的价值进行评价。结果中性粒细胞/淋巴细胞(NLR)、血小板/淋巴细胞(PLR)比值与肿瘤直径和核分裂相密切相关,高NLR、PLR比值(NLR〉2.4,PLR〉132)预示更大的肿瘤直径和更高的核分裂相;与Fletcher分级吻合(P〈0.05),随着NLR或PLR的增大,Fletcher分级加重,GIST侵袭危险度上升。NLR、PLR在预测GIST侵袭危险度方面差异无统计学意义(P=0.445)。结论中性粒细胞/淋巴细胞(NLR)、血小板/淋巴细胞(PLR)比值与GIST肿瘤恶性指标和Fletcher分级密切相关,是一种临床上可行、有效的预测GIST恶性度的新指标。 Objective To determine the correlations of neutrophil-to-lymphocyte ratio(NLR)and platelet-to-lymphocyte ratio (PLR) with the Fletcher grading of gastrointestinal stromal tumors (GIST). Methods Clinical data of 49 patients diagnosed with GIST from February 2005 to December 2012 at the Second Guangdong Provincial People’s Hospital were analyzed retrospectively. We evaluated the correlation of NLR and PLR with maximum tumor diameter,mitotic figures as well as the Fletcher grading. The application of these two parameters for predicting prognostic risk of GIST before surgery was also assessed. Results Significant correlations of NLR and PLR with clinicopathological features of GIST were confirmed , with the higher ratios (NLR〉2.4,PLR〉132) associating with larger tumor size and more mitotic figures. Also,the two parameters were positively correlated with Fletcher grading system(P〈0.05),with higher NLR or PLR suggesting higher Fletcher grades and more invasiveness of GIST. No statistical significance was found between NLR and PLR in predicting prognostic risk of GIST(P=0.445). Conclusion NLR and PLR correlate closely with malignant features and Fletcher grading system of GIST,and therefore can be considered as two feasible novel clinical parameters for predicting tumor prognostic risk.
出处 《中华生物医学工程杂志》 CAS 2015年第2期125-129,共5页 Chinese Journal of Biomedical Engineering
关键词 胃肠道间质瘤 中性粒细胞/淋巴细胞 血小板/淋巴细胞 Gastrointestinal stromal tumors Neutrophil-to-lymphocyte ratio (NLR) Platelet-to-lymphocyte ratio (PLR) Fletcher grading system
  • 相关文献

参考文献23

  • 1Hirota S,Isozaki K.Pathology of gastrointestinal stromal tumors[J].Pathol Int,2006,56(1):1-9.
  • 2Rossi CR,Mocellin S,Mencarelli R,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach[J].Int J Cancer,2003,107(2):171-176.
  • 3Corless CL,Fletcher JA,Heinrich MC.Biology of gastrointestinal stromal tumors[J].J Clin Oncol,2004,22(18):3813-3825.
  • 4Stamatakos M,Douzinas E,Stefanaki C,et al.Gastrointestinal stromal tumor[J].World I Surg Oncol,2009,7:61.
  • 5Walsh SR,Cook EJ,Goulder F,et al.Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer[J].J Surg Oncol,2005,91(3):181-184.
  • 6Smith RA,Bosonnet L,Raraty M,et al.Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma[J].Am J Surg,2009,197(4):466-472.
  • 7史恩溢,侯英勇,谭云山,周晓燕,蔡旭,陆永明,朱雄增.局限性胃肠道间质瘤危险程度分级标准的应用与评价[J].中华病理学杂志,2007,36(10):649-653. 被引量:18
  • 8Perez DR,Baser RE,Cavnar MJ,et al.Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor[J].Ann Surg Oncol,2013,20(2):593-599.
  • 9Fletcher CD,Berman JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:a consensus approach[J].Int J SurgPathol,2002,10(2):81-89.
  • 10Souto JC,Vila L,Bni A.Polymorphonuclear neutrophils and cancer:intense and sustained neutrophilia as a treatment against solid tumors[J].Med Res Rev,2011,31(3):311-363.

二级参考文献16

  • 1詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 2梁玉梅,李向红,吕有勇,吕亚莉,钟梅,蒲小璐,李文梅.胃肠道间质瘤156例临床病理学特征与预后的分析[J].中华病理学杂志,2007,36(4):233-238. 被引量:15
  • 3Raut CP, Morgan JA, Ashley SW. Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol, 2007, 23(2) : 149-158.
  • 4Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal turnouts, lancet Oncol, 2002, 3 (11) : 655-664.
  • 5Fletcher CD, Berman JJ, Corless CL, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002,33 (5) :459-465.
  • 6Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med, 2006,130 (10) : 1466-1478.
  • 7DeMatteo R, Owzar K, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup Phase Ⅲ trial ACOSOG Z9001. J Clin Oncol, 2007, 25(18S) :10079.
  • 8Miettinen M, Majidi M, Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer,2002, 38 (Suppl 5) : S39-S.51.
  • 9Parfitt JR, Streutker CJ, Riddell RH, et al. Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract, 2006, 202(12) : 837-847.
  • 10Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005,29(1) :52-68.

共引文献17

同被引文献25

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部